Source: International Congress 2014 – COPD and PAH related imaging
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Choudhury, A. Fletcher, M. Connell, T. Clark, S. Ferguson, R. Rabinovich, N. Weir, B. Whitcher, I. Kilty, W. Vennart, E. J. R. van Beek, W. MacNee (Edinburgh, United Kingdom; Cambridge, United States Of America). 18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 650

Member's Comments

No comment yet.

Related content which might interest you: 18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 18F-Fluorodeoxyglucose (18FDG) PET pulmonary imaging: Role in detecting vascular inflammation Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 18F-fluorodeoxyglucose (18F-FDG) PET/CT assessment of aortic inflammation and calcification in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004 Quantitative dynamic contrast-enhanced MRI of the lung in asthma Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014 Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers Source: Annual Congress 2005 - New modalities and application in lung and airway imaging Year: 2005 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDGPET) may be useful in the management of sarcoidosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Emerging diagnostics from MRI, PET and CT studies of lung disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Relation of high resolution computed tomography findings with functional parameters in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003 Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques Source: Eur Respir J 2007; 29: 418-422 Year: 2007 Functional lung MRI in COPD: Comparative assessment of T1 mapping, oxygen-enhanced T1 mapping and perfusion MRI at 1.5 Tesla Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014 COPD phenotypes by high resolution computed tomography (HRCT) and ventilatory response to exercise Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001